In a prostatectomy, what does 50% nerve spares imply for a patient with prostate cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Understanding "50% Nerve Sparing" in Prostatectomy

"50% nerve sparing" in prostatectomy refers to unilateral nerve-sparing surgery, where the neurovascular bundle is preserved on only one side of the prostate, as opposed to bilateral nerve-sparing where both bundles are preserved. This terminology reflects the anatomical reality that there are two neurovascular bundles (left and right) running along the posterolateral aspects of the prostate, and preserving one side represents approximately 50% preservation 1.

Impact on Erectile Function Recovery

The degree of nerve preservation directly determines erectile function outcomes:

  • Bilateral nerve-sparing (100% preservation) achieves potency rates of 72% overall, with age-stratified outcomes of 86% in men ≤49 years, 76% in men 50-59 years, 58% in men 60-69 years, and 37% in men ≥70 years 2.

  • Unilateral nerve-sparing (50% preservation) results in significantly lower potency rates of 53% overall, with only 39% achieving potency in some series 2, 3. The odds ratio for bilateral versus unilateral nerve-sparing is 2.9, meaning bilateral preservation nearly triples the likelihood of potency recovery 2.

  • Age dramatically modulates outcomes: In men younger than 60 years with full preoperative erections who had bilateral nerve-sparing, 76% recovered full erections, while only 7.5% of men older than 65 years with diminished preoperative function who had unilateral bundle resection recovered potency 1.

Impact on Urinary Continence

Nerve-sparing status significantly affects continence recovery, not just erectile function 4:

  • Urinary incontinence rates are 1% with bilateral nerve-sparing, 3% with unilateral nerve-sparing, and 14% without nerve-sparing 5.

  • Nerve-sparing surgery has an odds ratio of 4.77 for maintaining continence compared to non-nerve-sparing approaches 5.

  • At 12 months, continence recovery occurs in 86.4% with nerve-sparing versus 74.6% without nerve-sparing (p=0.022) 6.

Clinical Decision-Making for Unilateral Nerve-Sparing

The decision to perform unilateral rather than bilateral nerve-sparing is driven by oncologic considerations 4:

  • Multiparametric MRI has good specificity (0.91) but low sensitivity (0.57) for detecting extraprostatic extension, making preoperative selection challenging 4.

  • Nomograms incorporating mpMRI perform better than individual clinical or radiological factors for selecting appropriate nerve-sparing candidates 4.

  • The fundamental principle is that nerve-sparing should never compromise complete tumor excision 5, 3. When tumor extends to one neurovascular bundle, unilateral preservation on the contralateral side represents the optimal balance between oncologic control and functional preservation.

Recovery Timeline and Rehabilitation

Recovery is gradual and often delayed:

  • Maximal erectile function may not return until 12-24 months after surgery 1.

  • Early pharmacologic stimulation with phosphodiesterase-5 inhibitors may improve late recovery of sexual function 4, 1.

  • Nerve grafts to replace resected bundles do not appear effective, emphasizing that prevention of injury is more important than attempted repair 4, 1.

Common Pitfalls

The most critical caveat is that attempting bilateral nerve-sparing when tumor characteristics warrant wider excision increases positive margin rates and compromises cancer control 3. Completeness of tumor excision correlates primarily with tumor extent, making patient selection paramount 3. Patients with focal, well-differentiated tumors are ideal candidates for bilateral preservation, while those with high-volume, poorly differentiated tumors require more aggressive resection even if this necessitates unilateral or no nerve-sparing 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.